Previous 10 | Next 10 |
2023-11-03 12:14:31 ET DENVER, Colo., Nov. 3, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Werewolf Therapeutics Inc (NASDAQ: HOWL), Plus Therapeutics Inc (NASDAQ: PSTV), Tenon Medical Inc (...
2023-11-03 10:05:39 ET Volatility and Opportunity with Penny Stocks Penny stocks , also known as micro-cap equities or stocks under $5 per share, offer investors affordable opportunities. This is to buy shares in emerging small companies early before potential growth and upside. How...
2023-11-03 09:53:11 ET DENVER, Colo., Nov. 3, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Werewolf Therapeutics Inc (NASDAQ: HOWL), Plus Therapeutics Inc (NASDAQ: PSTV), Tenon Medical Inc (NASDAQ: TNO...
2023-11-03 07:34:30 ET More on Plus Therapeutics Plus Therapeutics, Inc. (PSTV) Q3 2023 Earnings Call Transcript Plus Therapeutics, Inc. (PSTV) Q2 2023 Earnings Call Transcript Biocept gains on licensing pact with Plus Therapeutics for cancer test Seeking Alp...
2023-11-03 07:27:34 ET DENVER, Colo., Nov 3, 2023 ( www.247marketnews.com )- Plus Therapeutics, Inc. (Nasdaq: PSTV) stated, this morning, that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to rhenium (186Re) obisbemeda for the treatment of breast ...
AUSTIN, Texas, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system cancers, today annou...
2023-10-31 19:46:02 ET Plus Therapeutics, Inc. (PSTV) Q3 2023 Earnings Conference Call October 31, 2023, 5:00 PM ET Corporate Participants Marc Hedrick - President and Chief Executive Officer Andrew Sims - Vice President and Chief Financial Officer Norman LaFranc...
2023-10-31 16:17:53 ET More on Plus Therapeutics Plus Therapeutics, Inc. (PSTV) Q2 2023 Earnings Call Transcript Biocept gains on licensing pact with Plus Therapeutics for cancer test Seeking Alpha’s Quant Rating on Plus Therapeutics Historical earning...
2023-10-31 16:11:19 ET More on Plus Therapeutics Plus Therapeutics, Inc. (PSTV) Q2 2023 Earnings Call Transcript Biocept gains on licensing pact with Plus Therapeutics for cancer test Seeking Alpha’s Quant Rating on Plus Therapeutics Historical earning...
New survival data from 15 patients in the Phase 2 ReSPECT-GBM trial of rhenium ( 186 Re) obisbemeda in recurrent glioblastoma (rGBM) will be presented at SNO Annual Meeting on November 17 th ; Company will also host a Key Opinion Leader (KOL) event following the meeting to...
News, Short Squeeze, Breakout and More Instantly...
PLUS THERAPEUTICS Inc. Company Name:
PSTV Stock Symbol:
NYSE Market:
PLUS THERAPEUTICS Inc. Website:
AUSTIN, Texas, July 02, 2024 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS...
Greg Fuller, M.D., Ph.D., former Professor of Pathology (Neuro-Pathology) & Neuro-Radiology at The University of Texas MD Anderson Cancer Center joins Plus as Vice President of Medical Affairs and Medical Director Plus receives notice of an additional $3.3 million CPRIT advance paym...
Announced private placement of up to $19.25M with healthcare funds and insiders Received $3M award recommendation from the Department of Defense to support Plus’ clinical brain cancer program Acquired synergistic leptomeningeal metastases diagnostic portfolio and announce...